Kumar A - Search Results

1

Impact of obesity on surgical and oncologic outcomes in ovarian cancer.

Kumar A, Bakkum-Gamez JN, Weaver AL, McGree ME, Cliby WA. Kumar A, et al. Gynecol Oncol. 2014 Oct;135(1):19-24. doi: 10.1016/j.ygyno.2014.07.103. Epub 2014 Aug 7. Gynecol Oncol. 2014. PMID: 25110330

2

Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival.

Patel K, Foster NR, Kumar A, Grudem M, Longenbach S, Bakkum-Gamez J, Haddock M, Dowdy S, Jatoi A. Patel K, et al. Among authors: kumar a. Support Care Cancer. 2015 May;23(5):1303-9. doi: 10.1007/s00520-014-2482-y. Epub 2014 Oct 23. Support Care Cancer. 2015. PMID: 25339620 Free PMC article.

3

Ureteral obstruction in cancer patients: a qualitative study.

Kumar A, Mynderse L, Patel K, Grudem M, Bakkum-Gamez J, Longenbach S, Block MS, Pitot HC, Garovic V, Weroha SJ, Jatoi A. Kumar A, et al. Psychooncology. 2016 May;25(5):605-9. doi: 10.1002/pon.3889. Epub 2015 Jun 22. Psychooncology. 2016. PMID: 26101949 No abstract available.

4

Surgical morbidity and clinical outcomes in ovarian cancer - the role of obesity.

Smits A, Lopes A, Das N, Kumar A, Cliby W, Smits E, Bekkers R, Massuger L, Galaal K. Smits A, et al. Among authors: kumar a. BJOG. 2016 Jan;123(2):300-8. doi: 10.1111/1471-0528.13585. BJOG. 2016. PMID: 26331299 Review.

5

Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer.

Kumar A, Janco JM, Mariani A, Bakkum-Gamez JN, Langstraat CL, Weaver AL, McGree ME, Cliby WA. Kumar A, et al. Gynecol Oncol. 2016 Jan;140(1):15-21. doi: 10.1016/j.ygyno.2015.10.025. Epub 2015 Nov 2. Gynecol Oncol. 2016. PMID: 26541980

6

Performance of AGO score for secondary cytoreduction in a high-volume U.S. center.

Janco JM, Kumar A, Weaver AL, McGree ME, Cliby WA. Janco JM, et al. Among authors: kumar a. Gynecol Oncol. 2016 Apr;141(1):140-7. doi: 10.1016/j.ygyno.2016.01.027. Epub 2016 Feb 2. Gynecol Oncol. 2016. PMID: 26836496

7

Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer.

Kumar A, Moynagh MR, Multinu F, Cliby WA, McGree ME, Weaver AL, Young PM, Bakkum-Gamez JN, Langstraat CL, Dowdy SC, Jatoi A, Mariani A. Kumar A, et al. Gynecol Oncol. 2016 Aug;142(2):311-6. doi: 10.1016/j.ygyno.2016.05.027. Epub 2016 Jun 2. Gynecol Oncol. 2016. PMID: 27235857

8

Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible.

Wallace S, Kumar A, Mc Gree M, Weaver A, Mariani A, Langstraat C, Dowdy S, Bakkum-Gamez J, Cliby W. Wallace S, et al. Among authors: kumar a. Gynecol Oncol. 2017 Apr;145(1):21-26. doi: 10.1016/j.ygyno.2017.01.029. Epub 2017 Jan 31. Gynecol Oncol. 2017. PMID: 28159407

9

Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer.

Kumar A, Torres ML, Cliby WA, Kalli KR, Bogani G, Aletti G, Nitschmann CC, Multinu F, Weaver AL, Block MS, Mariani A. Kumar A, et al. Anticancer Res. 2017 Jul;37(7):3673-3677. doi: 10.21873/anticanres.11738. Anticancer Res. 2017. PMID: 28668859 Free article.

10

Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer.

Kumar A, Langstraat CL, DeJong SR, McGree ME, Bakkum-Gamez JN, Weaver AL, LeBrasseur NK, Cliby WA. Kumar A, et al. Gynecol Oncol. 2017 Oct;147(1):104-109. doi: 10.1016/j.ygyno.2017.07.126. Epub 2017 Jul 19. Gynecol Oncol. 2017. PMID: 28734497

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,133 results

Search Page

Filters